Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: A pilot study

被引：0
|
作者：
Kertes, PJ [1 ]
Britton, WA [1 ]
Leonard, BC [1 ]
机构：
[1] UNIV OTTAWA, INST EYE, OTTAWA, ON, CANADA
来源：
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE | 1997年 / 32卷 / 03期
关键词：
age-related macular degeneration; choroidal neovascularization; interferon; drug toxicity; TOXICITY;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：185 / 188
页数：4
相关论文
共 50 条
  • [31] Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Fang, Kai
    Tian, Jun
    Qing, Xueying
    Li, Shuai
    Hou, Jing
    Li, Juan
    Yu, Wenzhen
    Chen, Dafang
    Hu, Yonghua
    Li, Xiaoxin
    JOURNAL OF OPHTHALMOLOGY, 2013, 2013
  • [32] Morphological changes with Intravitreal Aflibercept for Treatment Resistant Neovascular Age-Related Macular Degeneration
    Wong, Lily
    Le Hong, Thomas Hai
    Broadhead, Geoffrey
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [33] Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration
    Gupta, Bhaskar
    Adewoyin, Temilade
    Patel, Sheryl-Kay
    Sivaprasad, Sobha
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (03) : 386 - 390
  • [34] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
  • [35] Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration
    Levy J.
    Shneck M.
    Rosen S.
    Klemperer I.
    Rand D.
    Weinstein O.
    Pitchkhadze A.
    Belfair N.
    Lifshitz T.
    International Ophthalmology, 2009, 29 (5) : 349 - 357
  • [36] Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
    Chew, Emily Y.
    LANCET, 2024, 403 (10432): : 1110 - 1111
  • [37] Systemic and intravitreal Bevacizumab (Avastin®) in neovascular age-related macular degeneration
    Michels, S.
    Prager, F.
    Geitzenauer, W.
    Lackner, B.
    Sacu, S.
    Weigert, G.
    Kriechbaum, K.
    Polak, K.
    Georgopoulos, M.
    Schmidt-Erfurth, U.
    SPEKTRUM DER AUGENHEILKUNDE, 2007, 21 (03) : 154 - 159
  • [38] Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration"
    Calugaru, Dan
    Calugaru, Mihai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2020, 13 (02) : 362 - 363
  • [39] Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
    Dan C?lug?ru
    Mihai C?lug?ru
    International Journal of Ophthalmology, 2020, (02) : 362 - 364
  • [40] Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Hang, Abraham
    Ngo, Taylor
    Virk, Jaipreet Singh
    Moussa, Kareem
    Moshiri, Ala
    Emami-Naeini, Parisa
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3781 - 3789
12345